Navigation Links
Olympus Biotech International Ltd and BonAlive Biomaterials Ltd Announce Distribution Agreement
Date:1/20/2013

TURKU, Finland and LIMERICK, Ireland, January 21, 2013 /PRNewswire/ --

BonAlive Biomaterials Ltd, a manufacturer of implantable medical devices and an emerging leader in indications involving the treatment of chronically infected bone, and Olympus Biotech International Ltd, a wholly owned company of Olympus Corporation focused on minimally-invasive regenerative therapies in bone and soft tissues, today announced the signing of a multi-year exclusive distribution agreement. Under the agreement, Olympus Biotech International will have exclusive distribution rights for the BonAlive® granules product line in Germany, France and the UK. The product line covers regenerative products for orthopaedic and trauma surgeries.

     (Logo: http://photos.prnewswire.com/prnh/20130121/589026-a)

     (Logo: http://photos.prnewswire.com/prnh/20130121/589026-b)

The agreement is an important milestone in the commercialization strategy of the BonAlive® granules product line in the pathway of further expanding the access to hospitals in the large European markets.

"This newly established partnership enables us to work together with one of the most prominent leaders in the field of regenerative medicine in providing a complete portfolio of bone regeneration products to the community of orthopaedic and trauma surgeons" said Dr. Fredrik Ollila , CEO of BonAlive Biomaterials Ltd. "The establishment of a complete product offering will generate value and bring new opportunities in treatment of chronically infected bone".

"The cooperation and agreement with BonAlive Biomaterials Ltd completes our bone regeneration portfolio now also in the treatment of fractures and non-unions in patients with chronic infections. During our thorough global
'/>"/>

SOURCE BonAlive Biomaterials Ltd
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Olympus Introduces the Worlds First and Only Monopolar, Disposable Tonsil Adenoid Debrider (DTAD)
2. PROLOR Biotech To Present Preclinical Data On Its Long-Acting Clotting Factor Vlla At 2012 ASH Annual Meeting
3. XBiotech Reports Positive Phase II Interim Analysis Results in Vascular Disease
4. TNI BioTech, Inc. Signs Exclusive Distributor Agreement for Federal Republic of Nigeria with G-Ex Technologies/St. Maris Pharma & GB Pharma Holdings LLC
5. Medical Marijuana Inc. Portfolio Company CanChew BioTechnologies Inc. Announces Final Three Days for Market Survey and Free Product Trial Registration
6. Cytos Biotechnology Ltd Reports Third Quarter 2012 Financial Results, Recent Development and Outlook
7. RayBiotech, Inc. and Abeome Corporation Announce an Agreement Related to Novel Research Products for Ovarian Cancer
8. XBiotech Reports Positive Phase II Interim Analysis Results From Type 2 Diabetes Study
9. Goodwin Biotechnology is a Three-Category Winner in the 2012 CMO Leadership Awards
10. Mersana Therapeutics Named a "Fierce 15" Biotech Company for 2012
11. Lifeline Biotechnologies Receives Third Software Patent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... Mass. , Aug. 20, 2014 /PRNewswire/ ... electrophysiology (EP) mapping and ablation device market ... use ablation to treat atrial fibrillation (AF). ... primary treatment option for AF will spur ... this application, such as advanced loop diagnostic ...
(Date:8/20/2014)... , Aug. 20, 2014  Glades Drugs, an independent ... is proud to announce its expansion into a new corporate ... will feature an 8,000-square-foot office space and state of the ... applications for 100 open positions for the new facility. ... Lantana Road will serve as the chain,s corporate headquarters and ...
(Date:8/20/2014)... 20, 2014 Reportlinker.com ... available in its catalogue: EMR 2014: ... http://www.reportlinker.com/p0833392/EMR-2014-The-Market-for-Electronic-Medical-Records.html Kalorama has ... records (EMR) for nearly a decade, and each ... findings. Our report has become the industry standard, ...
Breaking Medicine Technology:Electrophysiology Mapping and Ablation Device Market in Japan to Reach $1.1 Billion by 2023 2Electrophysiology Mapping and Ablation Device Market in Japan to Reach $1.1 Billion by 2023 3Glades Drugs Moves to New Corporate Headquarters, 100 Open Positions 2EMR 2014: The Market for Electronic Medical Records 2EMR 2014: The Market for Electronic Medical Records 3EMR 2014: The Market for Electronic Medical Records 4EMR 2014: The Market for Electronic Medical Records 5EMR 2014: The Market for Electronic Medical Records 6EMR 2014: The Market for Electronic Medical Records 7EMR 2014: The Market for Electronic Medical Records 8
... 30 Transgenomic, Inc. (OTC,Bulletin Board: TBIO), a ... National Cancer Institute had approved a proposal to,perform ... in,the NCI 60 cancer cell line panel., ... warning,signal in several different types of cancer. This ...
... Spherix Incorporated,(Nasdaq: SPEX ) announced today that it ... manufacturer of bulk pharmaceutical ingredients,to supply a portion of ... of the unique sugar as a treatment for Type ... Practice) production batches,of D- tagatose for the Spherix New ...
Cached Medicine Technology:Transgenomic Establishes Collaboration With the National Cancer Institute to Investigate Mitochondrial Genome and Associated Nuclear Genes in Cancer Cell Lines 2Transgenomic Establishes Collaboration With the National Cancer Institute to Investigate Mitochondrial Genome and Associated Nuclear Genes in Cancer Cell Lines 3Spherix D-tagatose to be Supplied by Inalco SpA 2
(Date:8/20/2014)... Bronson Gray HealthDay Reporter ... extremely rare, colds, flu and other minor infections might trigger ... in children, a new study suggests. Just five out ... United States, said Dr. Heather Fullerton, lead author of the ... University of California, San Francisco Benioff Children,s Hospital. "It seems ...
(Date:8/20/2014)... NY (PRWEB) August 20, 2014 The ... firm Perkins Eastman is pleased to announce ... services in China and the surrounding ... Principal Richard Sprow AIA has relocated to ... 40-year career in healthcare planning and design and to ...
(Date:8/20/2014)... Utah (PRWEB) August 20, 2014 With 3943.8% ... 2014 list of the nation’s fastest growing companies. The Inc. ... the health care sector. Connexion Point is the #1 fastest ... centers in Medicare and Medicaid, and its clients include four ... Connexion Point employs 1,000 people and has offices and contact ...
(Date:8/20/2014)... that the amygdala stimulates stress responses in adults, ... University have found that the amygdala has an ... development of nonhuman primates. , The results are ... . , The amygdala is a region of ... to threatening situations and learning about threats. Alterations ...
(Date:8/20/2014)... -- New research reveals that, long ago, sea mammals ... of the infectious disease known as tuberculosis. Ancient ... seals and sea lions, who then spread it to ... to an international team of researchers. "Tuberculosis is ... This study and further research will help us understand ...
Breaking Medicine News(10 mins):Health News:Study Ties Colds, Flu to Rare Risk of Stroke in Kids 2Health News:Study Ties Colds, Flu to Rare Risk of Stroke in Kids 3Health News:Perkins Eastman Expands Presence in China 2Health News:Perkins Eastman Expands Presence in China 3Health News:With 3943.8% Growth, Connexion Point, a Leader in Contact Centers for Health Care, Ranks 86th on the Inc. 500 List as One of the Nation’s Fastest Growing Companies 2Health News:Maturing brain flips function of amygdala in regulating stress hormones 2Health News:Maturing brain flips function of amygdala in regulating stress hormones 3Health News:Seals, Sea Lions Helped Global Spread of TB, Study Finds 2
... program linking chronically ill older adults to home or ... new study.// ,“It’s not just medical or ... author Gretchen Alkema of the Davis School of Gerontology ... ,The study appears in the latest online ...
... A significant academic insight into the factors that enhance the ... Psychiatry.// ,The research, a unique endeavor of its ... from New Craigs Hospital in Inverness, indicates a relationship between ... risk of suicide on the later child. A study conducted ...
... currently used in many commercial gadgets may cause visible ... like the pacemaker, with fatal consequences. ... into the market recently and are silver in appearance. ... grey iron magnets. Since the cost of production of ...
... school students and volunteers of non-governmental organisations Friday took ... fight against the deadly disease.// ,Carrying banners ... to promote safe sex across the state during the ... government announced launch of an AIDS awareness drive in ...
... 2005-06 has revealed the extent of spousal violence//, HIV ... meted out to unmarried women. The survey spanned 29 ... organizations who were involved in accumulating data., ,There ... Vice-President, ORC Macro said, "Child marriage, for instance, declined ...
... find nonasthmatics share similar symptoms as those with asthma ... 2003, multiple wildfires raged throughout Southern California. Now, researchers// ... residents without asthma in wildfire-endangered regions suffered as much ... in the Dec. 1 print issue of the American ...
Cached Medicine News:Health News:Phone-Based Care Program Reduces Risk of Death in Older Adults 2Health News:Magnets in Commercial Products may Cause a Fatal Attraction 2Health News:Southern California Wildfires Pose Health Risks to Children 2
... The series SV stereomicroscopes are ... Thanks to their mature modular ... the job in hand. This ... of demanding routine applications will ...
10:1 Zoom Ratio - The parallel optical system of the SMZ-1000 has a 10:1 zoom with clickstops at 1X intervals. It features a zoom range of 0.8X to 8.0X and total magnification (depending on eyepieces...
... ratio of 15:1, a zoom ... and the convenience of clickstops ... to 11X, observation becomes easier ... to 540X can be obtained ...
Inquire...
Medicine Products: